Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of the study is to determine whether AL-15469A is safe and effective in the treatment of bacterial conjunctivitis.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Moxifloxacin | Experimental |
| |
| VIGAMOX | Active Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Moxifloxacin Alternative Formulation Ophthalmic Solution 0.5% | Drug | 1 drop into the conjunctival sac of both eyes 3 times a day for 3 days |
|
| Measure | Description | Time Frame |
|---|---|---|
| Clinical cure and microbiological success |
| Measure | Description | Time Frame |
|---|---|---|
| Individual signs and symptoms of bacterial conjunctivitis at each visit |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Contact Alcon for Trial Locations | Fort Worth | Texas | 76134 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 21681652 | Result | Tauber S, Cupp G, Garber R, Bartell J, Vohra F, Stroman D. Microbiological efficacy of a new ophthalmic formulation of moxifloxacin dosed twice-daily for bacterial conjunctivitis. Adv Ther. 2011 Jul;28(7):566-74. doi: 10.1007/s12325-011-0037-x. Epub 2011 Jun 14. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003234 | Conjunctivitis, Bacterial |
| ID | Term |
|---|---|
| D015818 | Eye Infections, Bacterial |
| D001424 | Bacterial Infections |
| D001423 | Bacterial Infections and Mycoses |
| D007239 | Infections |
Not provided
Not provided
| ID | Term |
|---|---|
| D000468 | Alkalies |
| D000077266 | Moxifloxacin |
| ID | Term |
|---|---|
| D007287 | Inorganic Chemicals |
| D024841 | Fluoroquinolones |
| D042462 | 4-Quinolones |
| D015363 | Quinolones |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Moxifloxacin hydrochloride ophthalmic solution 0.5% as base | Drug | 1 drop into the conjunctival sac of both eyes 3 times a day for 3 days |
|
|
| D015817 | Eye Infections |
| D003231 | Conjunctivitis |
| D003229 | Conjunctival Diseases |
| D005128 | Eye Diseases |
| D011804 |
| Quinolines |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006571 | Heterocyclic Compounds |